Drug intelligence / Profile preview

9Z,11E-conjugated linoleic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**9Z,11E-conjugated linoleic acid** (c9,t11-CLA) is a specific isomer of conjugated linoleic acid (CLA), a naturally occurring fatty acid primarily found in meat and dairy from ruminant animals[2][3][4][5]. CLA consists of different isomers, but the 9Z,11E/cis-9, trans-11 isomer is the most abundant and biologically active form in food sources. 9Z,11E-CLA has potential mechanisms of action that include modulation of lipid metabolism, reduction of body fat, anti-inflammatory and immunomodulatory effects, anti-cancer properties, and cardiovascular benefits[2][4][5]. Its biological effects are thought to be mediated by interactions with nuclear receptors such as peroxisome proliferator-activated receptor gamma (PPARγ), modulating gene expression involved in fat metabolism, inflammation, cell proliferation, and apoptosis[4]. Some studies suggest this isomer can increase adiponectin and endothelial nitric oxide synthase activity, inhibit matrix metalloproteinases involved in tumor invasion, and exert neuroprotective effects[4]. 9Z,11E-CLA is marketed as a dietary supplement for weight loss, metabolic health, and cancer prevention, but human evidence is inconclusive and safety concerns exist regarding insulin resistance and lipid profiles[1][3][5]. There are no pharmaceutical formulations of pure 9Z,11E-CLA; it is typically present as part of multi-isomer CLA dietary supplements.

Brand names
ClarinolPamolyn 300Pamolyn300Pamolyn-300
Other names
cis-9, trans-11 conjugated linoleic acidc9,t11-CLAconjugated linoleic acid
02

Targets

NOS3 (eNOS)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)

Beyond the preview

Go deeper on 9Z,11E-conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 9Z,11E-conjugated linoleic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call